|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4995 | (2006.01) |
| A61K 31/4995 | (2013.01) | ||
| A61K 31/554 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61K 31/7042 | (2006.01) | ||
| A61P 17/04 | (2018.01) | ||
| A61K 38/05 | (2006.01) | ||
| A61K 31/7042 | (2013.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61K 31/554 | (2013.01) | ||
| A61P 17/04 | (2006.01) | ||
| A61K 38/05 | (2013.01) |
| (11) | Number of the document | 3923943 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20755296.9 |
| Date of filing the European patent application | 2020-02-12 | |
| (97) | Date of publication of the European application | 2021-12-22 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2020/017951 |
| Date | 2020-02-12 |
| (87) | Number | WO 2020/167964 |
| Date | 2020-08-20 |
| (30) | Number | Date | Country code |
| 201962804523 P | 2019-02-12 | US | |
| 201962863904 P | 2019-06-20 | US | |
| 201962908431 P | 2019-09-30 | US | |
| 201962932015 P | 2019-11-07 | US |
| (72) |
JAECKLIN, Thomas , CH
DORENBAUM, Alejandro , US
|
| (73) |
Mirum Pharmaceuticals, Inc. ,
989 E Hillsdale Blvd., Suite 300, Foster City, CA 94404,
US
|
| (54) | GENOTYPE AND DOSE-DEPENDENT RESPONSE TO AN ASBTI IN PATIENTS WITH BILE SALT EXPORT PUMP DEFICIENCY |
| GENOTYPE AND DOSE-DEPENDENT RESPONSE TO AN ASBTI IN PATIENTS WITH BILE SALT EXPORT PUMP DEFICIENCY |